Multi-target dopamine D3 receptor modulators: Actionable knowledge for drug design from molecular dynamics and machine learning.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
15 Feb 2020
Historique:
received: 05 06 2019
revised: 02 12 2019
accepted: 16 12 2019
pubmed: 16 1 2020
medline: 18 2 2020
entrez: 16 1 2020
Statut: ppublish

Résumé

Local changes in the structure of G-protein coupled receptors (GPCR) binders largely affect their pharmacological profile. While the sought efficacy can be empirically obtained by introducing local modifications, the underlining structural explanation can remain elusive. Here, molecular dynamics (MD) simulations of the eticlopride-bound inactive state of the Dopamine D3 Receptor (D3DR) have been clustered using a machine learning-based approach in the attempt to rationalize the efficacy change in four congeneric modulators. Accumulating extended MD trajectories of receptor-ligand complexes, we observed how the increase in ligand flexibility progressively destabilized the crystal structure of the inactivated receptor. To prospectively validate this model, a partial agonist was rationally designed based on structural insights and computational modeling, and eventually synthesized and tested. Results turned out to be in line with the predictions. This case study suggests that the investigation of ligand flexibility in the framework of extended MD simulations can assist and inform drug design strategies, highlighting its potential role as a powerful in silico counterpart to functional assays.

Identifiants

pubmed: 31940507
pii: S0223-5234(19)31127-4
doi: 10.1016/j.ejmech.2019.111975
pii:
doi:

Substances chimiques

Carbamates 0
Dopamine Agonists 0
Dopamine Antagonists 0
Ligands 0
Piperazines 0
Receptors, Dopamine D3 0
Salicylamides 0
eticlopride J8M468HBH4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111975

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Mariarosaria Ferraro (M)

Istituto di Chimica Del Riconoscimento Molecolare, Consiglio Nazionale Delle Ricerche (ICRM-CNR), Via Mario Bianco 9, 20131, Milan, Italy. Electronic address: mariarosaria.ferraro@icrm.cnr.it.

Sergio Decherchi (S)

Computational & Chemical Biology, Italian Institute of Technology, Via Morego 30, 16163, Genoa, Italy. Electronic address: sergio.decherchi@iit.it.

Alessio De Simone (A)

Sygnature Discovery Ltd, Bio City, Pennyfoot St, Nottingham NG1 1GR, United Kingdom. Electronic address: a.desimone@sygnaturediscovery.com.

Maurizio Recanatini (M)

Dept. of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126, Bologna, Italy. Electronic address: maurizio.recanatini@unibo.it.

Andrea Cavalli (A)

Computational & Chemical Biology, Italian Institute of Technology, Via Morego 30, 16163, Genoa, Italy; Dept. of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126, Bologna, Italy. Electronic address: andrea.cavalli@iit.it.

Giovanni Bottegoni (G)

School of Pharmacy, University of Birmingham, Sir Robert Aitken Institute for Clinical Research, Edgbaston, B15 2TT, United Kingdom. Electronic address: g.bottegoni@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH